This study compared the efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-TSCPC) using different sweep velocities in refractory glaucoma. Twenty-eight eyes of 28 patients were treated with a slow-sweep protocol (20 s × 4 sweeps per hemisphere, fluence = 104.8 J/cm), and 29 eyes of 26 patients were treated with a regular-sweep protocol (10 s × 8 sweeps per hemisphere, fluence = 52.4 J/cm). Patients were evaluated at 1, 3, and 6 months to assess intraocular pressure (IOP), best-corrected visual acuity (BCVA), number of medications, and complications. The regular-sweep group achieved significantly greater mean IOP reduction at 1 month (-12.1 vs. - 4.8 mmHg, P < 0.001) and 3 months (-10.5 vs. - 3.6 mmHg, P = 0.003). At 6 months, no significant change in BCVA from baseline was observed in either group (all P > 0.05), while both protocols significantly reduced topical IOP-lowering medication use (all P < 0.05). Complication rates did not differ significantly between groups (P = 0.738). Multivariable analysis identified higher baseline IOP (P = 0.005) and the regular-sweep protocol (P < 0.001) as predictors of greater IOP reduction. In refractory glaucoma, both regular- and slow-sweep velocity protocols of MP-TSCPC demonstrated effectiveness with a similar safety profile in IOP reduction after a short follow-up period.
Keywords: Intraocular pressure, Micropulse transscleral cyclophotocoagulation, Refractory glaucoma, Sweep velocity
Scientific reports
Journal Article
English
41462358
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.